Proton MR Spectroscopy of Polymicrogyria and Heterotopia

American Journal of Neuroradiology

Volumn 24, Issue 10, 2003, Pages 2077-2081

  Widjaja, Elysa ^a   Griffiths, Paul D ^b   Wilkinson, Iain D ^b  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLINE; CREATINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN MALFORMATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; FRONTAL LOBE; HETEROTOPIA; HUMAN; KRUSKAL WALLIS TEST; MALE; MICROGYRIA; PROTON NUCLEAR MAGNETIC RESONANCE; RANK SUM TEST; THREE DIMENSIONAL IMAGING; WHITE MATTER;

ABNORMALITIES; ADOLESCENT; ADULT; BRAIN; BRAIN DISEASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLINE; CHORISTOMA; CREATINE; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL RETARDATION; MIDDLE AGED;

EID: 0344823715     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. Classification system for malformations of cortical development: update 2001. Neurology 2001;57:2168-2178
2. Barkovich JA. Pediatric Neuroimaging. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2000:283-317
3. Mukonoweshuro W, Wilkinson ID, Griffiths PD. Proton MR spectroscopy of cortical tubers in adults with tuberous sclerosis complex. AJNR Am J Neuroradiol 2001;22:1920-1925
4. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58
5. Fulham MJ, Dietz MJ, Duyn JH, Shih HH, Alge JR, Di Chiro G. Transsynaptic reduction of N-acetyl-L-aspartate in cerebellar diaschisis: a proton MR spectroscopic imaging study. J Comput Assist Tomogr 1994;18:697-704
6. Castillo M, Kwock L. Proton MR spectroscopy of common brain tumours. Neuroimaging Clin Am 1998;8:733-752
7. Ricci PE. Proton MR spectroscopy in ischaemic stroke and other vascular disorders. Neuroimaging Clin N Am 1998;8:881-900
8. Hida K, Kwee IL, Nakada T. In vivo 1H and 31P NMR spectroscopy of the developing rat brain. Magn Reson Med 1992;23:31-36
9. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HBW. In vivo quantification of brain metabolites by 1H-MRS using water as internal standard. Magn Reson Imaging 1993;11: 107-118
10. Petroff OAC, Plebam LA, Spencer DD. Symbiosis between in vivo and in vitro nuclear magnetic resonance spectroscopy: the creatine, N-acetyl aspartate, glutamate, and GABA content of epileptic human brain. Magn Reson Imaging 1995;13:1197-1211
11. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatinine, and choline. NMR Biomed 1991; 4:47-52
12. Miller BL, Chang L, Booth R, et al. In vivo 1H-MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929-1935
13. Sener RN. Infantile tuberous sclerosis changes in the brain: proton MR spectroscopy findings. Comput Med Imag Graph 2000;24:19-24
14. Battaglia G, Arcelli P, Granata T, et al. Neuronal migration disorders and epilepsy: a morphological analysis of three surgically treated patients. Epilepsy Res 1996;26:49-58
15. Lee N, Radtke RA, Gray L, et al. Neuronal migration disorders: positron emission tomography correlations. Ann Neurol 1994;35: 290-297
16. Castillo M, Kwock L, Murkherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15
17. Kuzniecky R, Hetherington H, Pan J, et al. Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy. Neurology 1997;48:1018-1024
18. Kaminaga T, Kobayashi M, Abe T. Proton magnetic resonance spectroscopy in disturbances of cortical development. Neuroradiology 2001;43:575-580
19. Li LM, Cendes F, Bastos AC. Neuronal metabolic dysfunction in patients with cortical developmental malformations. Neurology 1998;50:755-759
20. Simone IL, Federico F, Tortorella C, et al. Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy. Epilepsia 1999;40:872-879
21. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonanace spectroscopy. Magn Reson Med 1993;30:424-437
22. Hashimoto T, Tayama M, Miyazaki M, et al. Developmental brain changes investigated with proton magnetic resonance spectroscopy. Dev Med Child Neurol 1995;37:398-405
23. Van der Knaap MS, Van der Grond J, Van Rijen PC, Faber JA, Valk J, Willemse K. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176: 509-515
24. Tedeschi G, Bertolino A, Righini A, et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995; 45:1384-1391
25. Hetherington HP, Mason GF, Pan JW, et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994;32:565-571
26. 1H NMR spectra of metabolites in the human. Proc Natl Acad Sci USA 1988;85:1821-1825